We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry. By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.
With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.
Swift Analytical is the UK distributor for the NanoCellect microfluidic flow cytometry platforms – the WOLF G1 and G2.
NanoCellect is committed to empowering every scientist to make discoveries one cell at a time, with modern and simple technologies to advance cell based assays that are affordable, compact, and easy-to-use. Our microfluidic flow cytometry platforms enable biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, CRISPR and basic research.
Source Genomics provides state-of-the-art laboratory services for high quality data delivery in Genomics, Epigenomics, Spatial Transcriptomics and Proteomics. Market leaders for Sanger Sequencing and Next-Generation Sequencing services including Nanopore Sequencing, Whole Genome Sequencing, Metagenomics and more. Source Genomics is a premium service provider for genomics services, supporting academia and drug discovery research at rapid turnaround times.
Visit our website here.
LevitasBio's mission is to advance science by providing researchers with new and powerful methods of cellular analysis through proprietary label-free Levitation Technology. This technology represents a novel approach to cell separation, enabling scientists to rescue samples of poor quality and yield higher quantity and quality cells without introducing bias. The LeviCell® platform performs cellular enrichment without antibody labels, dyes, or modifications. The platform is compatible will all cell and tissue types, and is notably improving results gained from analytical platforms such as single cell sequencing.
NanoCellect is committed to empowering every scientist to make discoveries one cell at a time, with modern and simple technologies to advance cell based assays that are affordable, compact, and easy-to-use. Our microfluidic flow cytometry platforms enable biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, CRISPR and basic research.
